(Q51770946)

12 April 2018

title

BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. (English)

1 reference

12 April 2018

0 references

Qing-fei Kong

1

1 reference

12 April 2018

Bo Sun

2

1 reference

12 April 2018

Guang-you Wang

3

1 reference

12 April 2018

Dong-xu Zhai

4

1 reference

12 April 2018

Li-li Mu

5

1 reference

12 April 2018

Dan-dan Wang

6

1 reference

12 April 2018

Jing-hua Wang

7

1 reference

12 April 2018

Rui Li

8

1 reference

12 April 2018

Hu-lun Li

9

1 reference

12 April 2018

language of work or name

English

0 references

publication date

1 March 2009

1 reference

12 April 2018

European Journal of Immunology

published in

1 reference

12 April 2018

volume

39

1 reference

12 April 2018

issue

3

1 reference

12 April 2018

page(s)

800-809

1 reference

12 April 2018

Multilineage potential of adult human mesenchymal stem cells

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Bone marrow stromal cells generate muscle cells and repair muscle degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Immunoregulation in experimental autoimmune myasthenia gravis--about T cells, antibodies, and endplates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Th17 cell induction and immune regulatory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Mechanisms of T regulatory cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

In vitro preprogramming of marrow stromal cells for myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

Identifiers

DOI

10.1002/EJI.200838729

1 reference

12 April 2018

1 reference

12 April 2018